Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Zsuzsanna Szabó, Balázs Dezső, Klára Fodor, Krisztián Szegedi, Tibor Flaskó, Erzsébet Szabó, Gábor Oláh, Éva Sipos, Nikoletta Dobos, János Gardi, Andrew V. Schally & Gábor Halmos. (2021) Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer. Molecules 26:5, pages 1253.
Crossref
Crossref
David D’Andrea, Fred Witjes, Francesco Soria & Shahrokh F. Shariat. 2019. Urologic Oncology. Urologic Oncology
337
349
.
Amikar Sehdev, Olumide Gbolahan, Brad A. Hancock, Melissa Stanley, Safi Shahda, Jun Wan, Howard H. Wu, Milan Radovich & Bert H. O’Neil. (2018) Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX. Clinical Cancer Research 24:24, pages 6204-6211.
Crossref
Crossref
David D’Andrea, Fred Witjes, Francesco Soria & Shahrokh F. Shariat. 2018. Urologic Oncology. Urologic Oncology
1
13
.
Angelo Rodrigues, Rui Henrique & Carmen Jeronimo. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer
537
545
.
Qiuli Liu, Wenqiang Yuan, Dali Tong, Gaolei Liu, Weihua Lan, Dianzheng Zhang, Hualiang Xiao, Yao Zhang, Zaoming Huang, Junjie Yang, Jun Zhang & Jun Jiang. (2016) Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis. Oncotarget 7:19, pages 28235-28246.
Crossref
Crossref
Syed A. Khurram, Paula M. Farthing, Abigail Whitworth, Alasdair J. McKechnie & Malee Fernando. (2016) High-grade urothelial carcinoma with squamous differentiation metastasizing to the tongue. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 121:5, pages e111-e115.
Crossref
Crossref
M. Rodríguez-Monsalve Herrero, P. Ramírez Rodríguez-Bermejo & I. Castillón Vela. (2015) Protocolo diagnóstico de la neoplasia de la vía urinaria. Medicine - Programa de Formación Médica Continuada Acreditado 11:83, pages 4984-4991.
Crossref
Crossref
Christopher S. Foster & George J. Netto. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
2322
2412
.
Richard T. Bryan. (2015) Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena. Philosophical Transactions of the Royal Society B: Biological Sciences 370:1661, pages 20140042.
Crossref
Crossref
Margaret A. Knowles & Carolyn D. Hurst. (2014) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nature Reviews Cancer 15:1, pages 25-41.
Crossref
Crossref
Sean McAdams & Michael C. Risk. 2015. Management of Bladder Cancer. Management of Bladder Cancer
45
57
.
Judith Knievel, Wolfgang Schulz, Annemarie Greife, Christiane Hader, Tobias Lübke, Ingo Schmitz, Peter Albers & Günter Niegisch. (2014) Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer. International Journal of Molecular Sciences 15:11, pages 20500-20517.
Crossref
Crossref
Jason Van Batavia, Tammer Yamany, Andrei Molotkov, Hanbin Dan, Mahesh Mansukhani, Ekaterina Batourina, Kerry Schneider, Daniel Oyon, Mark Dunlop, Xue-Ru Wu, Carlos Cordon-Cardo & Cathy Mendelsohn. (2014) Bladder cancers arise from distinct urothelial sub-populations. Nature Cell Biology 16:10, pages 982-991.
Crossref
Crossref
Ofer N. Gofrit, Galina Pizov, Amos Shapiro, Mordechai Duvdevani, Vladimir Yutkin, Ezekiel H. Landau, Kevin C. Zorn, Guy Hidas & Dov Pode. (2014) Mixed High and Low Grade Bladder Tumors—Are They Clinically High or Low Grade?. Journal of Urology 191:6, pages 1693-1696.
Crossref
Crossref
Christina U. Köhler, Laura Martin, Nadine Bonberg, Thomas Behrens, Thomas Deix, Katharina Braun, Joachim Noldus, Karl-Heinz Jöckel, Raimund Erbel, Florian Sommerer, Andrea Tannapfel, Volker Harth, Heiko U. Käfferlein & Thomas Brüning. (2014) Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer. Biochemical and Biophysical Research Communications 448:4, pages 467-472.
Crossref
Crossref
Hideyasu Matsuyama, Kenzo Ikemoto, Satoshi Eguchi, Atsunori Oga, Shigeto Kawauchi, Yoshiaki Yamamoto, Yoshihisa Kawai, Hiroaki Matsumoto, Takahiko Hara, Kazuhiro Nagao, Shigeru Sakano & Kohsuke Sasaki. (2014)
Copy number aberrations using multicolour fluorescence
in situ
hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC)
. BJU International 113:4, pages 662-667.
Crossref
Crossref
Angelo Rodrigues, Rui Henrique & Carmen Jeronimo. 2016. Encyclopedia of Cancer. Encyclopedia of Cancer
1
11
.
De-Xiang Zhuo, Xiao-Wei Zhang, Bo Jin, Zheng Zhang, Bu-Shan Xie, Cheng-Lin Wu, Kan Gong & Ze-Bin Mao. (2013) CSTP1, a Novel Protein Phosphatase, Blocks Cell Cycle, Promotes Cell Apoptosis, and Suppresses Tumor Growth of Bladder Cancer by Directly Dephosphorylating Akt at Ser473 Site. PLoS ONE 8:6, pages e65679.
Crossref
Crossref
Raju Kandimalla, Angela A. van Tilborg & Ellen C. Zwarthoff. (2013) DNA methylation-based biomarkers in bladder cancer. Nature Reviews Urology 10:6, pages 327-335.
Crossref
Crossref
Yvonne Chekaluk, Chin-Lee Wu, Jonathan Rosenberg, Markus Riester, Qishan Dai, Sharron Lin, Yanan Guo, W. Scott McDougal & David J. Kwiatkowski. (2013) Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value. PLoS ONE 8:4, pages e60927.
Crossref
Crossref
David R. Yates, Morgan Rouprêt, Sarah J. Drouin, Marie Audouin, Géraldine Cancel-Tassin, Eva Comperat, Marc-Olivier Bitker & Olivier Cussenot. (2012) Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours. World Journal of Urology 31:1, pages 53-59.
Crossref
Crossref
Raju Kandimalla, Angela A.G. van Tilborg, Lucie C. Kompier, Dominique J.P.M. Stumpel, Ronald W. Stam, Chris H. Bangma & Ellen C. Zwarthoff. (2012) Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers. European Urology 61:6, pages 1245-1256.
Crossref
Crossref
David P. WoodJr.Jr.. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2309
2334.e6
.
Mark L. Gonzalgo & Alan Keith Meeker. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
530
567.e16
.
Roland Seiler, George N Thalmann & Achim Fleischmann. (2011) MMP-2 and MMP-9 in lymph-node-positive bladder cancer. Journal of Clinical Pathology 64:12, pages 1078-1082.
Crossref
Crossref
Takuji Tanaka, Katsuhito Miyazawa, Tetsuya Tsukamoto, Toshiya Kuno & Koji Suzuki. (2011) Pathobiology and Chemoprevention of Bladder Cancer. Journal of Oncology 2011, pages 1-23.
Crossref
Crossref
Anne J Grotenhuis, Sita H Vermeulen & Lambertus A Kiemeney. (2010) Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response. Future Oncology 6:9, pages 1433-1460.
Crossref
Crossref
Peter J. Goebell & Margaret A. Knowles. (2010) Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urologic Oncology: Seminars and Original Investigations 28:4, pages 409-428.
Crossref
Crossref
Peter J. Goebell, Susan G. Groshen & Bernd J. Schmitz-Dräger. (2010) p53 immunohistochemistry in bladder cancer—a new approach to an old question. Urologic Oncology: Seminars and Original Investigations 28:4, pages 377-388.
Crossref
Crossref
Catherine Seager, Anna M. Puzio‐Kuter, Carlos Cordon‐Cardo, James McKiernan & Cory Abate‐Shen. (2010) Mouse Models of Human Bladder Cancer as a Tool for Drug Discovery. Current Protocols in Pharmacology 49:1.
Crossref
Crossref
Marko Babjuk. (2010) New Insights in Intravesical Treatment for Intermediate- and High-Risk Non–Muscle-Invasive Urothelial Bladder Carcinoma. European Urology 57:5, pages 774-776.
Crossref
Crossref
Lucie C. Kompier, Angela A.G. van Tilborg & Ellen C. Zwarthoff. (2010) Bladder cancer: Novel molecular characteristics, diagnostic, and therapeutic implications. Urologic Oncology: Seminars and Original Investigations 28:1, pages 91-96.
Crossref
Crossref
Margaret A. Knowles, Fiona M. Platt, Rebecca L. Ross & Carolyn D. Hurst. (2009) Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer and Metastasis Reviews 28:3-4, pages 305-316.
Crossref
Crossref
Theodorus H van der Kwast & Bharati Bapat. (2009) Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling. Current Opinion in Urology 19:5, pages 516-521.
Crossref
Crossref
Anna M. Puzio-Kuter, Mireia Castillo-Martin, Carolyn W. Kinkade, Xi Wang, Tian Huai Shen, Tulio Matos, Michael M. Shen, Carlos Cordon-Cardo & Cory Abate-Shen. (2009)
Inactivation of
p53
and
Pten
promotes invasive bladder cancer
. Genes & Development 23:6, pages 675-680.
Crossref
Crossref